Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
NAII logo NAII
Upturn stock ratingUpturn stock rating
NAII logo

Natural Alternatives International (NAII)

Upturn stock ratingUpturn stock rating
$3.52
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

04/01/2025: NAII (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -61.24%
Avg. Invested days 22
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 04/01/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 21.39M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) 8372
Beta 0.6
52 Weeks Range 3.27 - 7.26
Updated Date 04/2/2025
52 Weeks Range 3.27 - 7.26
Updated Date 04/2/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.29

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -6.26%
Operating Margin (TTM) 7.87%

Management Effectiveness

Return on Assets (TTM) -3.65%
Return on Equity (TTM) -9.27%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 74829698
Price to Sales(TTM) 0.18
Enterprise Value 74829698
Price to Sales(TTM) 0.18
Enterprise Value to Revenue 0.61
Enterprise Value to EBITDA 74.97
Shares Outstanding 6198780
Shares Floating 4005619
Shares Outstanding 6198780
Shares Floating 4005619
Percent Insiders 21.52
Percent Institutions 34.36

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Natural Alternatives International

stock logo

Company Overview

overview logo History and Background

Natural Alternatives International (NAII) was founded in 1980. It began as a contract manufacturer of nutritional supplements. Over time, it has expanded its capabilities to include product development, testing, and global distribution, focusing on high-quality ingredients and scientific validation.

business area logo Core Business Areas

  • Contract Manufacturing: NAII provides contract manufacturing services for dietary supplements, nutritional ingredients, and other health-related products. This includes formulation development, manufacturing, packaging, and labeling.
  • Product Development: NAII develops its own branded products and also assists clients in developing custom formulations. The company also performs product testing and analysis.
  • Global Distribution: NAII distributes its products and its clients' products globally, leveraging its supply chain expertise and international partnerships.

leadership logo Leadership and Structure

Mark A. LeDoux is the Chairman of the Board and CEO. The company's organizational structure is designed to support its manufacturing, product development, and distribution operations, with dedicated teams for each area.

Top Products and Market Share

overview logo Key Offerings

  • CarnoSynu00ae Beta-Alanine: NAII's flagship ingredient, CarnoSynu00ae beta-alanine, is a patented and scientifically backed ingredient used in sports nutrition and dietary supplements to enhance athletic performance. Although NAII's market share data is not publicly available, they are a major player in the beta-alanine market with a strong brand reputation. Competitors: NNB Nutrition, Alzchem Trostberg GmbH.
  • SR CarnoSynu00ae Sustained Release Beta-Alanine: This is a sustained-release formulation of CarnoSyn, providing extended benefits. It caters to consumers looking for prolonged performance enhancement. Revenue data is not publicly available. Competitors: NNB Nutrition, Alzchem Trostberg GmbH.
  • Custom Formulations: NAII develops and manufactures custom formulations for various clients in the dietary supplement industry. Revenue data is not publicly available. Competitors are other contract manufacturers such as Nutra Manufacturing, Captek Softgel International.

Market Dynamics

industry overview logo Industry Overview

The dietary supplement industry is experiencing growth driven by increasing consumer awareness of health and wellness. Key trends include personalized nutrition, sports nutrition, and immune support. The industry is highly competitive and is subject to regulatory scrutiny.

Positioning

NAII is positioned as a science-backed and high-quality contract manufacturer and ingredient supplier. Its competitive advantages include patented ingredients, scientific validation, and quality control processes.

Total Addressable Market (TAM)

The global dietary supplements market is estimated to be around $200 billion (USD) and is projected to grow in the coming years. NAII is positioned to capture a portion of this TAM through its contract manufacturing services, patented ingredients like CarnoSyn, and global distribution network.

Upturn SWOT Analysis

Strengths

  • Patented ingredients (CarnoSynu00ae)
  • Strong R&D capabilities
  • High-quality manufacturing standards
  • Global distribution network
  • Science-backed products

Weaknesses

  • Customer concentration risk (reliance on a few large clients)
  • Limited brand recognition compared to large consumer brands
  • Vulnerable to raw material price fluctuations

Opportunities

  • Expanding into new international markets
  • Developing new innovative ingredients
  • Acquiring complementary businesses
  • Capitalizing on the growing demand for personalized nutrition
  • Increasing strategic partnerships

Threats

  • Increased competition from other contract manufacturers
  • Changing regulatory landscape
  • Economic downturn affecting consumer spending
  • Negative publicity or product recalls
  • Patent infringement

Competitors and Market Share

competitor logo Key Competitors

  • NUTR
  • GNC
  • HLTH

Competitive Landscape

NAII competes in both the branded ingredient and contract manufacturing spaces. It differentiates itself through scientific validation and high-quality standards. However, it faces competition from larger companies with greater brand recognition and distribution reach.

Major Acquisitions

Growth Trajectory and Initiatives

Historical Growth: NAII's growth has been driven by the increasing popularity of its CarnoSyn ingredient and its contract manufacturing services. Historic growth figures can be extracted from company financial reports.

Future Projections: Analyst estimates for NAII's future growth can be found on financial websites. It is based on CarnoSyn sales and also the increasing demand for contract manufacturing

Recent Initiatives: Recent initiatives may include new product launches, expansion into new markets, or strategic partnerships, which can be found in press releases and investor presentations.

Summary

Natural Alternatives International demonstrates strengths in patented ingredients and quality manufacturing. However, its smaller size and customer concentration pose risks. Growth opportunities lie in international expansion and new product development, but the company must navigate competitive pressures and regulatory changes. Overall, NAII presents a mixed profile with promising prospects tempered by inherent risks within the industry.

Similar Companies

HLTHratingrating

Cue Health Inc

$0.01
Small-Cap Stock
0%
PASS

HLTHratingrating

Cue Health Inc

$0.01
Small-Cap Stock
0%
PASS

Sources and Disclaimers

Data Sources:

  • NAII's SEC filings
  • NAII's investor relations website
  • Financial news websites
  • Industry reports

Disclaimers:

This analysis is based on publicly available information and should not be considered financial advice. Market share data is estimated and may not be precise.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Natural Alternatives International

Exchange NASDAQ
Headquaters Carlsbad, CA, United States
IPO Launch date 1987-03-13
Chairman of the Board & CEO Mr. Mark A. LeDoux J.D.
Sector Consumer Defensive
Industry Packaged Foods
Full time employees 296
Full time employees 296

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, the company sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​